The effect of peripheral opioid block and body cooling on sensitivity to heat in capsaicin-treated skin

Anesthesia and Analgesia

Volumn 90, Issue 4, 2000, Pages 923-927

  Drummond, Peter D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; NALOXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEAT SENSITIVITY; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; INDUCED HYPOTHERMIA; IONTOPHORESIS; MALE; NOCICEPTION; NORMAL HUMAN; PAIN THRESHOLD; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROVOCATION; SKIN INFLAMMATION;

EID: 0034035619     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200004000-00027     Document Type: Article

References (29)

1. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995;332:1685-90.
2. Koppert W, Likar R, Geisslinger G, et al. Peripheral antihyperalgesic effect of morphine to heat, but not mechanical, stimulation in healthy volunteers after ultraviolet-B radiation. Anesth Analg 1999;88:117-22.
3. Stein C, Hassan AHS, Lehrberger K, et al. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321-4.
4. Antonijevic I, Mousa SA, Schäfer M, Stein C. Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 1995;15:165-72.
5. Winter J, Bevan S, Campbell EA. Capsaicin and pain mechanisms. Br J Anaesth 1995;75:157-68.
6. Kinnman E, Nygårds EB, Hansson P. Peripherally administered morphine attenuates capsaicin-induced mechanical hypersensitivity in humans. Anesth Analg 1997;84:595-9.
7. Ko MC, Butelman ER, Woods JH. The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys. J Pharmacol Exp Ther 1998;286:150-6.
8. Park KM, Max MB, Robinovitz E, et al. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 1995;63:163-72.
9. Herz A. Peripheral opioid analgesia: facts and mechanisms. Prog Brain Res 1996;110:95-104.
10. Mogil JS, Sternberg WF, Balian H, et al. Opioid and nonopioid swim stress-induced analgesia: a parametric analysis in mice. Physiol Behav 1996;59:123-32.
11. Drummond PD. Independent effects of ischaemia and noradrenaline on thermal hyperalgesia in capsaicin-treated skin. Pain 1996;67:129-33.
12. Drummond PD. Enhancement of thermal hyperalgesia by α-adrenoceptors in capsaicin-treated skin. J Auton Nerv Syst 1998;69:96-102.
13. Levine JD, Gordon NC, Fields HL. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature 1979;278:740-1.
14. Kayser V. Endogenous opioid systems in the modulation of pain: behavioral studies in rat models of persistent hyperalgesia. In: Gebhart GF, Hammond DL, Jensen TS, eds. Progress in pain research and management, vol 2. Proceedings of the 7th World Congress on Pain. Seattle: IASP Press, 1994:553-68.
15. Rios L, Jacob JJC. Inhibition of inflammatory pain by naloxone and its N-methyl quaternary analogue. Life Sci 1982;31:1209-12.
16. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 1998;30:5-11.
17. Kiernan JA. A pharmacological and histological investigation of the involvement of mast cells in cutaneous axon reflex vasodilatation. Q J Exp Physiol Cog Med Sci 1975;60:123-30.
18. Coderre TJ, Basbaum AI, Levine JD. Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents. J Neurophysiol 1989;62:48-58.
19. Cabot PJ, Carter L, Gaiddon C, et al. Immune cell-derived β-endorphin: production, release, and control of inflammatory pain in rats. J Clin Invest 1997;100:142-8.
20. Quinlan KL, Song IS, Naik SM, et al. VCAM-1 expression on human dermal microvascular cells is directly and specifically up-regulated by substance P. J Immunol 1999;162:1656-61.
21. Casale TB, Bowman S, Kaliner M. Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J Allergy Clin Immunol 1984;73:775-81.
22. Levy JH, Brister NW, Shearin A, et al. Wheal and flare responses to opioids in humans. Anesthesiology 1989;70:756-60.
23. Withington DE, Patrick JA, Reynolds F. Histamine release by morphine and diamorphine in man. Anaesthesia 1993;48:26-9.
24. Hermens JM, Ebertz JM, Hanitin JM, Hirshman CA. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone. Anaesthesiology 1985; 62:124-9.
25. Nissen JB, Egekvist H, Bjerring P, Kragballe K. Effect of intradermal injection of methionine-enkephalin on human skin. Acta Derm Venereol 1999;79:23-6.
26. Wintzen M, Gilchrest BA. Proopiomelanocortin, its derived peptides, and the skin. J Invest Dermatol 1996;106:3-10.
27. Chadzinska M, Kolaczkowska E, Seljelid R, et al. Morphine modulation of peritoneal inflammation in Atlantic salmon and CB6 mice. J Leukoc Biol 1999;65:590-6.
28. Grossmann M, Jamieson MJ, Kellogg DL, et al. The effect of iontophoresis on the cutaneous vasculature: evidence for current-induced hyperemia. Microvasc Res 1995;50:444-52.
29. Magerl W, Szolcsányi J, Westerman RA, Handwerker HO. Laser Doppler measurements of skin vasodilation elicited by percutaneous electrical stimulation of nociceptors in humans. Neurosci Lett 1987;82:349-54.